期刊文献+

绿色荧光蛋白-去整合素融合蛋白的表达及其结合功能的研究 被引量:2

Expression of green fluorencent protein-disintegrin fusion protein and its binding to integrin on cells surface
在线阅读 下载PDF
导出
摘要 目的:构建绿色荧光蛋白(GFP)-去整合素(disintegrin)融合基因,表达并分析该重组蛋白的生物学活性。方法:利用HF-PCR扩增Ⅱ型蛇毒出血性金属蛋白酶agacutin基因的去整合素区,并与绿色荧光蛋白基因进行拼接;将GFP-去整合素融合基因克隆入表达载体pQE-30,IPTG诱导重组蛋白表达;流式细胞术(FCM)与荧光显微镜分析重组蛋白与细胞的结合能力。结果:GFP-去整合素融合蛋白的表达载体在大肠杆菌M15中得到有效表达,菌体呈绿色。表达的蛋白量占菌体总蛋白的38%左右,免疫印迹证实分子量约为39 kD;FCM分析显示该重组蛋白可与表达整合素的乳腺癌细胞MDA-MB-231和内皮细胞EA.hy926特异结合,在荧光显微镜下可见与重组蛋白结合的细胞发出绿色荧光。结论:GFP-去整合素融合蛋白可与表达整合素的细胞结合,并保留了各自的生物学活性,可用作肿瘤与血管生成等研究的新的分子标记物。 Objective:To construct green fluorencent protein(GFP)-disintegrin fusion gene for efficient expression and bioactivity analysis.Methods:Tbe agacutin gene fragment encoding its disintegrin region was amplified by HF-PCR and fused with GFP gene. The resulting fusion gene was then cloned into pQE-30 vector. The expression of fusion protein was induced by IPTG and identified by SDS-PAGE analysis and Western blot assay. The binding characterization of the recombinant protein was assayed with flow cytometry(FCM) and fluoressence microscope. Results:After induction of IPTG, recombinant protein was produced in E. coli M15 [ pREP4 ] with a major band at 39 kD, comprising up to 38% of the total cell protein, which was confirmed on SDS-PAGE and Western blotting. Recombiant GFP-disintegrin fusion protein could specifically bind to such integfin-expressing cells as breast cancer cell line MDA-MB-231 and endothelial cell line EA. hy926 in FCM analysis and these cells emit green fluorescence under the fluorescence microscope. Conclusion:Tbe recombinant GFP-disintegrin fusion protein maintains the activity of each of these two compounds, and can be used as a new molecular marker for study of tumor, angiogenesis, etc.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2005年第10期739-743,共5页 Chinese Journal of Immunology
基金 江苏省社会发展项目(BS2001070)
关键词 绿色荧光蛋白 去整合素 重组蛋白 血管生成 Disintegrin Green fluorencent protein Recombinant protein Angiogenesis
  • 相关文献

参考文献13

  • 1Plow E F, Haas T A, Zhang L et al. Ligand binding to integrins [J]. J Biol Chem, 2000;275:21785-21788.
  • 2Silletti S, Cheresh D A. A link between integrins and MMPs in angiogenesis [J]. Fibrinolysis Proteolysis, 1999;13:226-238.
  • 3Mousa S A. Anti-integrin as novel drug-discovery targets: potential therapeutic and diagnostic implications [J]. Curr Opin Chem Biol, 2002;6:534-541.
  • 4Kang I C, Kim D S, Jang Y et al. Suppressive mechanism of salmosin,a novel disintegrin, in B16 melanoma cell metastasis [J]. Biochem Biophys Res Commun, 2000;275:169-173.
  • 5Yeh C H, Peng H C, Huang T F. Accutin, a new disintegrin, inhibits angiogenesis in vitro and in vivo by acting as integrin αvβ3 antagonist and inducing apoptosis [J]. Blood, 1998;92:3268-3276.
  • 6Yang M, Baranov E, Wang J W et al. Direct external imaging of nascent cancer, tumor progression, angiogenesis, and metastasis on internal organs in the fluorescent orthotopic model [J]. Proc Natl Acad Sci USA,2002; 99: 3824-3829.
  • 7Morino K, Katsumi H, Akahori Y et al. Antibody fusions with fluorescent proteins: a versatile reagent for profiling protein expression [J]. J Immunol Methods, 2001;257:175-184.
  • 8Yeh C H, Peng H C, Yang R S et al. Rhodostomin, a snake venom disintegrin, inhibits angiogenesis elicited by basic fibroblast growth factor and suppresses tumor growth by a selective αvβ3 blockade of endothelial cells [J]. Mol Pharmacol, 2001;59:1333-1342.
  • 9Zhou Q, Sherwin R P, Parrish C et al. Contortostatin, a dimeric disintegrin from Agkistrodon contortrlx, inhibits breast cancer progression [J].Breast Cancer Res Treat,2000;61:249-260.
  • 10Janssen M L, Oyen W J, Dijkgraaf I et al. Tumor targeting with radiolabeled αvβ3 integrin binding peptides in a nude mouse model [J]. Cancer Res, 2002; 62: 6146-6151.

同被引文献25

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部